Cargando…

Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major

PURPOSE: Beta-thalassemia major is a severe, congenital hematological disorder and, if untreated, leads to early mortality. Progress in therapeutical strategies improved clinical outcomes and life expectancy; however, increased survival led to the development of new disorders, including endocrinopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrogio, Alberto G., Danesi, Leila, Baldini, Marina, Radin, Raffaella, Cassinerio, Elena, Graziadei, Giovanna, Mirra, Nadia, D’Angelo, Emanuela, Marcon, Alessia, Mancarella, Marta, Orsatti, Alessandra, Bonetti, Federico, Scacchi, Massimo, Cappellini, Maria Domenica, Persani, Luca, Pecori Giraldi, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893656/ https://www.ncbi.nlm.nih.gov/pubmed/29572711 http://dx.doi.org/10.1007/s12020-018-1562-z

Ejemplares similares

Pregnant women affected by thalassemia major: a controlled study of traits and personality
por: Messina, Giuseppina, et al.
Publicado: (2010)

Unexpected Genotype in a Non-Transfusion Dependent Thalassemia Family
por: Curcio, Cristina, et al.
Publicado: (2020)

Coagulopathy in Beta-Thalassemia: Current Understanding and Future Perspectives
por: Cappellini, M. Domenica, et al.
Publicado: (2009)

Cardiopulmonary testing in adult patients with β-thalassemia major in comparison to healthy subjects
por: Piatti, G., et al.
Publicado: (2022)

Oocyte quality in women with thalassaemia major: insights from IVF cycles
por: Mensi, Laura, et al.
Publicado: (2019)

Variability in laboratory parameters used for management of Cushing’s syndrome
por: Pecori Giraldi, Francesca, et al.
Publicado: (2015)

Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy
por: Motta, Irene, et al.
Publicado: (2021)

Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2022)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY
por: Marktel, S, et al.
Publicado: (2022)

Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications
por: Baldini, M., et al.
Publicado: (2014)

Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
por: Motta, Irene, et al.
Publicado: (2020)

Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia
por: Derchi, Giorgio, et al.
Publicado: (2022)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
por: Sleiman, Joseph, et al.
Publicado: (2018)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease
por: Ambrogio, Alberto Giacinto, et al.
Publicado: (2017)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
por: Ferraresi, Marta, et al.
Publicado: (2023)

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study
por: Cappellini, Maria Domenica, et al.
Publicado: (2019)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
por: Taher, Ali T, et al.
Publicado: (2016)

Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm
por: Musallam, Khaled M., et al.
Publicado: (2022)

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox
por: Taher, Ali T, et al.
Publicado: (2014)

Thalassemia Major: The Present and the Future
por: Baldini, Marina
Publicado: (2012)

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
por: Baronciani, Donatella, et al.
Publicado: (2021)

Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy
por: Musallam, Khaled M, et al.
Publicado: (2023)

Beta-thalassemia
por: Galanello, Renzo, et al.
Publicado: (2010)

Pregnancy in Thalassemia
por: Origa, Raffaella, et al.
Publicado: (2019)

Innovative Treatments for Rare Anemias
por: Cappellini, Maria Domenica, et al.
Publicado: (2021)

CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2021)

Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles
por: Cassarino, Maria Francesca, et al.
Publicado: (2018)

TSH-Suppressive Therapy: A Thorny Issue
por: Baldini, Itala Marina, et al.
Publicado: (2017)

Correction of β-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients
por: Roselli, Emanuela Anna, et al.
Publicado: (2010)

Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department
por: Forni, Gian Luca, et al.
Publicado: (2014)

Validation of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO(©))
por: Taher, Ali, et al.
Publicado: (2018)

Development of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO(©))
por: Taher, Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r8dnkueg8hqogfutj0lvdh0iha